Active, Not Recruiting Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) NCT06049212 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more Locations Aichi Cancer Center ( Site 0006) — Nagoya, Aichi-ken, Japan National Cancer Center Hospital East ( Site 0002) — Kashiwa, Chiba, Japan National Hospital Organization Shikoku Cancer Center ( Site 0008) — Matsuyama, Ehime, Japan Kanagawa Cancer Center ( Site 0004) — Yokohama, Kanagawa, Japan View more locations Show fewer locations Loading locations... View Trial Details
